International Flavors & Fragrances CapEx decreased by 12.2% to $165.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.8%, from $179.00M to $165.00M. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 10.9% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.00M | $77.00M | $151.00M | $132.00M | $104.00M | $108.00M | $160.00M | $175.00M | $115.00M | $100.00M | $113.00M | $118.00M | $82.00M | $103.00M | $160.00M | $179.00M | $95.00M | $132.00M | $188.00M | $165.00M |
| QoQ Change | — | +6.9% | +96.1% | -12.6% | -21.2% | +3.8% | +48.1% | +9.4% | -34.3% | -13.0% | +13.0% | +4.4% | -30.5% | +25.6% | +55.3% | +11.9% | -46.9% | +38.9% | +42.4% | -12.2% |
| YoY Change | — | — | — | — | +44.4% | +40.3% | +6.0% | +32.6% | +10.6% | -7.4% | -29.4% | -32.6% | -28.7% | +3.0% | +41.6% | +51.7% | +15.9% | +28.2% | +17.5% | -7.8% |